The global anti-peptic ulcer drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Anti-peptic ulcer drugs are among the various classes of drugs with different action mechanisms used to treat or reduce peptic ulcers or irritation of the gastrointestinal tract. Further, H. pylori, the spiral-shaped bacteria can damage the stomach and duodenum lining and cause peptic ulcer disease. The market growth is majorly attributed to the exceptionally growing prevalence of peptic ulcers all over the globe. As per the National Institutes of Health (NIH), about 30 to 40% of people in the US get an H. pylori infection. In most cases, the infection remains dormant, or quiet without signs or symptoms, for years. Most people get an H. pylori infection as a child.

Another key trend observed in the market includes the growing preference of patients toward peptic ulcer drugs over surgeries. This is anticipated to be a major factor to augment the global anti-peptic ulcer drugs market during the forecast period. In addition to this, the increasing focus of the key players of the market on the research and development activities coupled with the rising number of generic drugs manufacturers of peptic ulcer drugs are also likely to offer lucrative opportunities for market growth. Further, stressed lifestyles, as well as a significant rise in the patient pool with H. pylori infection, will also raise the demand for these drugs in the future years. 

Market Coverage

• The market number available for – 2021-2028

• Base year- 2021

• Forecast period- 2022-2028

• Segment Covered- 

o By Product Type

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  AstraZeneca plc, and Takeda Pharmaceutical Co., Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Anti-Peptic Ulcer Drugs Market Report by Segment

By Product Type

• Proton Pump Inhibitors

• Antacids

• Potassium-Competitive Acid Blockers (P-CAB)

• H2 Antagonist

• Others

By Application

• Gastritis

• Gastric Ulcers

• Duodenal Ulcers

• Gastroesophageal Reflux Disease (GERD)

Global Anti-Peptic Ulcer Drugs Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa